IPO Year: 2024
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|
SINGAPORE, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced Dr. Siaw Tung Yeng and Dr. Rachel Teoh Pui Pui, Co-Founders and Co-CEOs, will present and host one-on-one meetings with investors at the Sidoti August Virtual Investor Conference, taking place on August 14-15, 2024. Joining them will be Law Pei Bei, Chief Business Officer, Peng Chee Yong, Chief Financial Officer, and Lan Kangming, Investor Relations Officer. The presentation will begin at 8:30 AM ET on Wednesday, August 14 and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_1RrAEeydShatO
Ryde Group Ltd (NYSE:RYDE) ("Ryde" or "the Company"), a leading technology platform for mobility and quick commerce, today announced a partnership with Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr"), the first US listed telehealth provider in Asia Pacific. Ryde and MaNaDr signed a definitive partnership agreement to further collaboration in the telehealth and quick commerce space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240627298820/en/(Left to right: Dr Rachel Teoh, Co-Founder and Co-CEO, Dr Siaw Tung Yeng, Co-Founder and Co-CEO, Mr. Terence Zou, Founder, Chairman, and CEO & Mr. Nitin Dolli, Chief Technology Of
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announces the latest major update to its cloud-based MaNaDr AI-Powered Health Operating System ("MHOS") designed to transform healthcare delivery on a global scale. Streamlined Operations, Enhanced Care The latest MHOS boasts a suite of powerful features that empower clinics to significantly improve efficiency and patient care. Its key strengths include: Superior Performance: Reduced registration times, streamlined electronic health record ("EHR") system for primary care with functionality to support t
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal 2024 ("H1FY24") ended December 31, 2023, the Company had revenue of approximately $6.6 million, approximately a 120% improvement on revenue of $3.0 million for the same period in fiscal 2023 ("H1FY23"). Telemedicine consultations on the platform increased by approximately 101% during H1FY24, reaching 731,000 compared to 363,000 during H1FY23. The Company believes that this growth was driven by both increased adoption rates and a larger market share. Coupled with the
Gainers Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92% to $40.0. The company's market cap stands at $519.2 million. Geovax Labs (NASDAQ:GOVX) shares rose 28.94% to $2.45. The company's market cap stands at $6.1 million. SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 24.03% to $3.2. The market value of their outstanding shares is at $29.5 million. Trevena (NASDAQ:TRVN) stock rose 23.33% to $0.44. The market value of their outstanding shares is at $8.0 million. Molecular Partners (NASDAQ:MOLN) stock rose 22.23% to $9.73. The company's
Mobile-health Network Solutions ['MaNaDr'](NASDAQ:MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight management program, improving the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medications?in the Asia-Pacific (APAC) region.
Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal 2024 ("H1FY24") ended December 31, 2023, the Company had revenue of approximately $6.6 million, approximately a 120% improvement on revenue of $3.0 million for the same period in fiscal 2023 ("H1FY23").Telemedicine consultations on the platform increased by approximately 101% during H1FY24, reaching 731,000 compared to 363,000 during H1FY23. The Company believes that this growth was driven by both increased adoption rates and a larger market share. Coupled with the implementation of a dynamic pricing model which increas
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K/A - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)